38 studies found for:    Open Studies | "Meningitis"
Show Display Options
Rank Status Study
21 Recruiting Auditory Brainstem Implantation in Young Children
Conditions: Developmental Cochlear Nerve Deficiency;   Acquired Cochlear Nerve Deficiency;   Cochlear Aplasia;   Post-meningitis Cochlear Ossification;   Cochlear Malformation
Intervention: Device: Auditory Brainstem Implantation in Children
22 Not yet recruiting Understanding Pneumococcal Carriage and Disease
Conditions: Meningitis;   Septicaemia;   Pneumonia
Intervention:
23 Recruiting Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine
Condition: Meningitis
Interventions: Biological: Minhai Bio;   Biological: Hualan Bio
24 Not yet recruiting Investigating the Immune Response to 4CMenB in Infants
Condition: Meningitis
Intervention: Biological: 4CMenB
25 Recruiting Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
Conditions: Pneumonia;   Meningitis;   Bacteraemia;   Sepsis;   Otitis Media
Intervention: Biological: Prevenar 13 and Synflorix
26 Recruiting Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care
Conditions: Sepsis;   Bacteraemia;   Meningitis;   Abscess;   Pneumonia;   Osteomyelitis;   Cellulitis;   Gastro-enteritis With Dehydration;   Complicated Urinary Tract Infection;   Viral Respiratory Infection Complicated With Hypoxia
Interventions: Device: Use of C-reactive protein (CRP) point of care test;   Other: Brief intervention and parent leaflet;   Device: Finger Pulse Oximeter
27 Recruiting Feeding Bovine Colostrum to Preterm Infants
Conditions: Feeding Intolerance;   Necrotizing Enterocolitis;   Meningitis;   Sepsis
Intervention: Dietary Supplement: Bovine colostrum
28 Recruiting Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
Condition: Meningitis
Interventions: Biological: MCV-ACYW135 Vaccine Group;   Biological: MPV-ACYW135 Vaccine Group;   Biological: MPV-A Vaccine Group;   Biological: MCV-AC Vaccine Group;   Biological: Hib Vaccine Group
29 Recruiting A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients
Conditions: Profound Bilateral Deafness Due to;   Bilateral Cochlear Aplasia;   Bilateral Cochlear Nerve Deficiency;   Bilateral Cochlear Ossification Secondary to Meningitis
Intervention: Device: Auditory Brainstem Implant
30 Unknown  Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Metastatic Cancer
Interventions: Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique;   Procedure: magnetic resonance imaging
31 Recruiting Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningitis
Condition: Women at Risk of Neonatal Infections Colonize With GBS (Group B Streptococci).
Intervention: Other: Samples
32 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
33 Not yet recruiting Safety and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.
Condition: Meningococcal Disease
Interventions: Biological: Meningoccal B recombinant vaccine together with routine vaccines: DTaP-IPV-Hib, HepB, PCV (2-4-6 months of age) and MMRV (12 months of age);   Biological: Routine vaccines: DTaP-IPV-Hib, HepB, PCV (2-4-6 months of age) and MMRV (12 months of age)
34 Recruiting Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects
Condition: Meningococcal Disease
Intervention: Biological: rMenB+OMV
35 Unknown  High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement
Condition: B-Cell Lymphomas
Intervention: Drug: High-dose sequential chemotherapy and autologous transplant
36 Recruiting Safety Surveillance of MenACWY-CRM Vaccine in Children
Condition: Meningococcal Disease
Intervention: Biological: MenACWY-CRM
37 Recruiting Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
Condition: Meningococcal Disease
Interventions: Biological: MenABCWY;   Biological: MenACWY
38 Recruiting Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: rMenB+OMV and MenACWY;   Biological: rMenB+OMV;   Biological: MenACWY

Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page
Indicates status has not been verified in more than two years